Cargando…

MiR‐335‐5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2

OBJECTIVE: Our study was designed to explore the association miR‐335‐5p and BCL2L2 and to investigate the influence of miR‐335‐5p/BCL2L2 axis on cisplatin‐resistant ovarian cancer cells. METHODS: Microarray analysis was used to determine differentially expressed microRNAs in primary and cisplatin‐re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ruonan, Guo, Hailong, Lu, Shifen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143943/ https://www.ncbi.nlm.nih.gov/pubmed/30019389 http://dx.doi.org/10.1002/cam4.1682

Ejemplares similares

An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression
por: Safaric Tepes, Polona, et al.
Publicado: (2021)

miR‐140‐3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2
por: Liu, Dingsheng, et al.
Publicado: (2021)

Up‐regulation of miR‐497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl‐2
por: Zhu, Danhua, et al.
Publicado: (2017)

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
por: Oliveira, Sara R., et al.
Publicado: (2021)

Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
por: Cittelly, Diana M., et al.
Publicado: (2010)

Long non-coding RNA XIST regulates ovarian cancer progression via modulating miR-335/BCL2L2 axis
por: Meng, Qingjuan, et al.
Publicado: (2021)

Characterization of miR-335-5p and miR-335-3p in human osteoarthritic tissues
por: Wilson, Thomas G., et al.
Publicado: (2023)

Nonconserved miR‐608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 pathways by targeting the 3′‐UTRs of RAC2/BCL2L1 and the coding region of PAK4
por: Zhang, Xu, et al.
Publicado: (2019)

Circ‐UBAP2 functions as sponges of miR‐1205 and miR‐382 to promote glioma progression by modulating STC1 expression
por: Wang, Jianxin, et al.
Publicado: (2021)

Functions and Targets of miR-335 in Cancer
por: Ye, Lingling, et al.
Publicado: (2021)

LncRNA H19 interacted with miR‐130a‐3p and miR‐17‐5p to modify radio‐resistance and chemo‐sensitivity of cardiac carcinoma cells
por: Jia, Jianguang, et al.
Publicado: (2019)

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015)

Expression profiles of miRNAs in giant cell tumor of bone showed miR‐187‐5p and miR‐1323 can regulate biological functions through inhibiting FRS2
por: Jin, Yuanhan, et al.
Publicado: (2020)

Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR‐760/SOCS3 pathway
por: Li, Li, et al.
Publicado: (2020)

Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells
por: Weiner-Gorzel, Karolina, et al.
Publicado: (2015)

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway
por: Yang, Ying, et al.
Publicado: (2021)

MAGI2‐AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR‐525‐5p/MXD1 axis
por: Chang, Hua, et al.
Publicado: (2020)

HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
por: Dong, Yu-Jie, et al.
Publicado: (2021)

MiR‐646 suppresses proliferation and metastasis of non‐small cell lung cancer by repressing FGF2 and CCND2
por: Wang, Jing, et al.
Publicado: (2020)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer
por: Zeng, Zhao‐lei, et al.
Publicado: (2021)

miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1
por: Ding, Xiangfu, et al.
Publicado: (2017)

Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
por: Keremu, Ajimu, et al.
Publicado: (2019)

Hypoxia‐responsive miR‐124 and miR‐144 reduce hypoxia‐induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1
por: Gu, Hao, et al.
Publicado: (2016)

MiR-335 promotes corneal neovascularization by Targeting EGFR
por: Qian, Jingjing, et al.
Publicado: (2022)

Downregulated miR‐144‐3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2
por: Liu, Chao, et al.
Publicado: (2018)

TP53 mediated miR‐3647‐5p prevents progression of cervical carcinoma by targeting AGR2
por: Liu, Ronghua, et al.
Publicado: (2019)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR‐155‐5p
por: Tong, Lingling, et al.
Publicado: (2019)

Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR‐1184/IGFBP2 axis
por: Yang, Dengke, et al.
Publicado: (2019)

miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3
por: Kim, Youngmi, et al.
Publicado: (2015)

MiR‐24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1
por: Kang, Min, et al.
Publicado: (2016)

The mechanism study of miR‐125b in occurrence and progression of multiple myeloma
por: Gao, Da, et al.
Publicado: (2017)

Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211
por: Zhang, Hairong, et al.
Publicado: (2021)

LncRNA NEAT1 knockdown attenuates autophagy to elevate 5‐FU sensitivity in colorectal cancer via targeting miR‐34a
por: Liu, Fen, et al.
Publicado: (2019)

LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway
por: Zhang, Xiao-Mei, et al.
Publicado: (2020)

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2017)

miR‐548d‐3p/TP53BP2 axis regulates the proliferation and apoptosis of breast cancer cells
por: Song, Qiong, et al.
Publicado: (2015)

MiR‐3130‐5p is an intermediate modulator of 2q33 and influences the invasiveness of lung adenocarcinoma by targeting NDUFS1
por: Zhan, Juan, et al.
Publicado: (2021)

Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2
por: Liu, Qian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jkbp7fvm7rl2e39rv4j8v821va